Haematologica, Vol 92, Issue 6, 861-862 doi:10.3324/haematol.10914
Copyright © 2007 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Auewarakul, C. U.
Right arrow Articles by Thongnoppakhun, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Auewarakul, C. U.
Right arrow Articles by Thongnoppakhun, W.

Acute Myeloid Leukemia

AML1 mutation and its coexistence with different transcription factor gene families in de novo acute myeloid leukemia: redundancy or synergism

Chirayu U. Auewarakul*,, Amporn Leecharendkeat°, Chintana Tocharoentanaphol#, Orathai Promsuwicha*, Narongrit Sritana#, Wanna Thongnoppakhun@

* Department of Medicine,
° Department of Immunology; Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
# Chulabhorn Cancer Centre, Chulabhorn Research Institute, Bangkok, Thailand
@ Office of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

Correspondence: Chirayu U. Auewarakul, MD, PhD, Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Prannok Rd, Bangkoknoi, Bangkok 10700, Thailand. Phone: international +662.4197000/4449: Fax: international +662.4181602. E-mail: chirayuaue{at}yahoo.com

AML1 mutations were identified in 6.3% of AML patients with chromosomal translocations involving CBF, PML-RAR{alpha}, HOX, or ETS transcription factor (TF) gene families. Rare chromosomal abnormalities, t(16;21) and t(7;11), were also found. This study represents the first series to demonstrate the coexistence of known and novel AML1 mutations with different TF gene mutations. Although the occurrence of two TF gene mutations may appear unnecessary, the possible synergistic mechanism between different TF gene families cannot be excluded and needs to be further explored.

Key words: acute myeloid leukemia, transcription factor, AML1 mutation, leukemogenesis, cooperative events.




This article has been cited by other articles:


Home page
 haematolHome page
C. Boonthimat, W. Thongnoppakhun, and C. U. Auewarakul
Nucleophosmin mutation in Southeast Asian acute myeloid leukemia: eight novel variants, FLT3 coexistence and prognostic impact of NPM1/FLT3 mutations
Haematologica, October 1, 2008; 93(10): 1565 - 1569.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Roche-Lestienne, L. Deluche, S. Corm, I. Tigaud, S. Joha, N. Philippe, S. Geffroy, J.-L. Lai, F.-E. Nicolini, C. Preudhomme, et al.
RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance
Blood, April 1, 2008; 111(7): 3735 - 3741.
[Abstract] [Full Text] [PDF]